Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron vs Ondansetron for Pediatric PONV
NCT01395901Phase 3Completed
- Sponsor
- Helsinn
- Start
- Jun 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of palonosetron in postoperative nausea and vomiting (PONV), sponsored by Helsinn. Started Jun 2011; status: completed.
02
Drugs
palonosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT01395901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01395901.